Clinical Trials Logo

Filter by:
NCT ID: NCT00842218 Recruiting - Scoliosis Clinical Trials

The Idiopathic Scoliosis and Its Treatment (Orthopaedic and Surgery): Effect of the Severity, the Orthosis and the Arthrodesis on the Gait

scoliosis
Start date: January 2009
Phase: N/A
Study type: Observational

The purposes of this study were as follows: 1) to compare locomotion parameters (kinematic, EMG, mechanical work and energy cost changes during walking in able-bodied subjects and AIS patients,2) to evaluate the effects of the frontal curve's severity of the AIS and 3) the effects of the treatment (orthosis or surgery)on these gait parameters.

NCT ID: NCT00838240 Recruiting - Leukemia Clinical Trials

Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia

AML-14A
Start date: November 2008
Phase: Phase 1/Phase 2
Study type: Interventional

RATIONALE: Drugs used in chemotherapy, such as clofarabine, cytarabine, and idarubicin, work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells. PURPOSE: This randomized phase I/II trial is studying the side effects and best dose of clofarabine and to see how well it works when given together with cytarabine and idarubicin in treating patients with intermediate-risk or high-risk acute myeloid leukemia or high-risk myelodysplasia.

NCT ID: NCT00825929 Recruiting - HIV Infections Clinical Trials

Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.

PANNA
Start date: February 2009
Phase:
Study type: Observational

Due to the potential for pregnancy-induced changes in the pharmacokinetics of medication, one cannot assume that the currently licensed doses of the medication to be tested under this protocol lead to adequate exposure in an HIV-infected pregnant woman. For the agents under study no or limited pharmacokinetic data during pregnancy are available. As the changes in pharmacokinetics during pregnancy are most prominent in the third trimester a pharmacokinetic curve will be recorded in the third trimester after attaining steady state.

NCT ID: NCT00799162 Recruiting - Postoperative Pain Clinical Trials

Prediction of Post-Cesarean Section Pain

PPCSP
Start date: November 2008
Phase: N/A
Study type: Observational

The purpose of this study is to determine if dynamic psychophysical testing along with genetic screening will allow to identify pre-operatively women who will suffer severe acute pain post-operatively and the subset who may experience chronic pain following cesarean section.

NCT ID: NCT00798785 Recruiting - Clinical trials for Diabetes Mellitus, Type 1

Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients

Start date: October 2006
Phase: Phase 1/Phase 2
Study type: Interventional

The present proof of concept study addresses the following specific aims: The general objectives of this work are: 1. To increase and maintain the functional beta-cell mass after islet transplantation under a condition of low-dose tacrolimus 2. To co-investigate the potential of alternative sites for encapsulated beta-cells

NCT ID: NCT00781612 Recruiting - Neoplasm Metastasis Clinical Trials

A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies

Start date: October 16, 2008
Phase: Phase 2
Study type: Interventional

This is a global, multicenter, open-label safety extension study. Participants receiving single-agent trastuzumab emtansine or trastuzumab emtansine administered in combination with other anti-cancer therapies in a Genentech / Roche-sponsored parent study who are active and receiving benefit at the closure of parent study are eligible for continued treatment in this study.

NCT ID: NCT00729287 Recruiting - Bladder Cancer Clinical Trials

Selenium in Preventing Cancer Recurrence in Patients With Bladder Cancer

Start date: June 2008
Phase: Phase 3
Study type: Interventional

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of selenium may keep bladder cancer from growing or coming back. It is not yet known whether selenium is more effective than a placebo in preventing cancer recurrence in patients with bladder cancer. PURPOSE: This randomized phase III trial is studying selenium to see how well it works compared with a placebo in preventing cancer recurrence in patients with bladder cancer.

NCT ID: NCT00727623 Recruiting - Clinical trials for Acute Myocardial Infarction

Mortality Analysis of ST Elevation Myocardial Infarction (STEMI) Patients in Belgium

Start date: July 2007
Phase:
Study type: Observational

The purpose of this observational study is to assess predictors of in-hospital mortality in patients with acute myocardial infarction admitted to Belgian hospitals.

NCT ID: NCT00727350 Recruiting - Clinical trials for Non Small Cell Lung Carcinoma

Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma.

Start date: March 2007
Phase: Phase 2
Study type: Interventional

The study population will exist of patients with a histological diagnosis of NSCLC, stage T1, T2 or T3NO who are not fit for or who refuse surgery. A prospective data analysis will be performed on tumor response, potential acute and late toxicity and survival. A radiotherapy dose of 4x15Gy or 3x 20Gy will be given over 2 weeks with dynamic 3D-conformal arc therapy (Novalis TM)

NCT ID: NCT00716222 Recruiting - Obesity Clinical Trials

Hormonal and Metabolic Consequences of Sleep Disorders in Young Obese Patients

SOM
Start date: May 2008
Phase: N/A
Study type: Observational

There is a well-documented relationship between short sleep duration and high body mass index (BMI). The mechanism linking short sleep duration and weight gain is unknown. Current studies in healthy young volunteers have shown that experimental sleep restriction is associated with dysregulation of the neuroendocrine control of appetite and with alterations in glucose metabolism. The goal of our study is to determine the metabolic and hormonal modifications induced by chronic sleep curtailment in obese adolescents and young adults and to observe if short sleep is a negative prognostic factor in their weight evolution.